These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 18189220

  • 1. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B, Eger K, Kornhuber ME, Zierz S.
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
    [Abstract] [Full Text] [Related]

  • 2. [Neuromyelitis optica: a clinical update].
    Chiquete E, Navarro-Bonnet J, Ayala-Armas R, Gutiérrez-Gutiérrez N, Solórzano-Meléndez A, Rodríguez-Tapia D, Gómez-Rincón M, Ruiz-Sandoval JL.
    Rev Neurol; 2010 Sep 01; 51(5):289-94. PubMed ID: 20669128
    [Abstract] [Full Text] [Related]

  • 3. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T, Fujihara K, Itoyama Y.
    Brain Nerve; 2008 May 01; 60(5):527-37. PubMed ID: 18516975
    [Abstract] [Full Text] [Related]

  • 4. Neuromyelitis optica: changing concepts.
    Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG.
    J Neuroimmunol; 2007 Jul 01; 187(1-2):126-38. PubMed ID: 17512987
    [Abstract] [Full Text] [Related]

  • 5. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.
    Rinsho Byori; 2009 Mar 01; 57(3):262-70. PubMed ID: 19363997
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.
    Nat Clin Pract Neurol; 2008 Apr 01; 4(4):202-14. PubMed ID: 18334978
    [Abstract] [Full Text] [Related]

  • 7. [Neuromyelitis optica/Devic's syndrome: new perspectives].
    Lalive PH, Perrin L, Chofflon M.
    Rev Med Suisse; 2007 Apr 11; 3(106):950-5. PubMed ID: 17575971
    [Abstract] [Full Text] [Related]

  • 8. Neuromyelitis optica.
    Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.
    Curr Opin Neurol; 2007 Jun 11; 20(3):255-60. PubMed ID: 17495617
    [Abstract] [Full Text] [Related]

  • 9. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
    Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H.
    Ann Neurol; 2009 Nov 11; 66(5):630-43. PubMed ID: 19937948
    [Abstract] [Full Text] [Related]

  • 10. [Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody].
    Ochi H.
    Brain Nerve; 2010 Sep 11; 62(9):945-52. PubMed ID: 20844305
    [Abstract] [Full Text] [Related]

  • 11. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P, Cayrol R, Vincent T.
    Autoimmun Rev; 2009 Dec 11; 9(2):132-5. PubMed ID: 19389490
    [Abstract] [Full Text] [Related]

  • 12. The spectrum of neuromyelitis optica.
    Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.
    Lancet Neurol; 2007 Sep 11; 6(9):805-15. PubMed ID: 17706564
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Wang KC, Tsai CP, Lee CL, Chen SY, Chen SJ.
    Eur Neurol; 2011 Sep 11; 65(2):99-104. PubMed ID: 21273778
    [Abstract] [Full Text] [Related]

  • 14. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.
    PLoS Med; 2007 Apr 11; 4(4):e133. PubMed ID: 17439296
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM.
    Neurologist; 2007 Jan 11; 13(1):2-11. PubMed ID: 17215722
    [Abstract] [Full Text] [Related]

  • 16. Devic's neuromyelitis optica: clinical and imaging findings.
    Vandevyver V, Lemmerling M, De Potter R, Verstraete K.
    JBR-BTR; 2007 Jan 11; 90(4):284-7. PubMed ID: 17966247
    [Abstract] [Full Text] [Related]

  • 17. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May 11; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 18. Neuromyelitis optica.
    Wingerchuk DM.
    Int MS J; 2006 May 11; 13(2):42-50. PubMed ID: 16635421
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G.
    Int J Neurosci; 2010 Jan 11; 120(1):71-5. PubMed ID: 20128675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.